Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
#How Has The Implantable Infusion Pumps Market Size Shifted, And What Is the Outlook Through 2034?
There has been a consistent expansion in the market size for implantable infusion pumps over the recent years. The market is projected to escalate from $19.59 billion in 2024 to $20.48 billion in 2025, with a compound annual growth rate (CAGR) of 4.6%. The substantial growth during the historic period can be linked to the management of chronic diseases, an aging demographic, pain management strategies, and regulatory authorisations.
How Much Will the Implantable Infusion Pumps Market Be Worth in 2029?
The market for implantable infusion pumps is anticipated to experience robust expansion in the upcoming years, projected to reach a size of $26.89 billion by 2029, scaling at a compound annual growth rate (CAGR) of 7.0%. This anticipated growth within the forecast period can be credited to factors such as personalized medicine, remote patient supervision, advancements in drug development, and management of chronic diseases. Key prediction trends for the period include less invasive implantation methods, remote observation and programming, intrathecal pain management, and interdisciplinary cooperation.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3347&type=smp
Which is the Largest Company in the Implantable Infusion Pumps Market?
Major companies operating in the implantable infusion pumps market include Medtronic plc, Boston Scientific Corporation, Nevro Corp, LivaNova PLC, Baxter International Inc., B. Braun Melsungen AG, Fresenius Kabi AG, Smiths Medical a Smiths Group company, Terumo Corporation, Johnson & Johnson, Greatbatch Medical, NeuroPace Inc., Primetech Corporation, Flowonix Medical Inc., F. Hoffmann-La Roche Ltd, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Micrel Medical, Insulet Corporation, ICU Medical Inc., Becton Dickinson and Company (BD), Roche Diagnostics International AG, Abbott Laboratories, Hospira, Stryker Corporation, Zimmer Biomet Holdings Inc., Teleflex Incorporated, C. R. Bard Inc., AngioDynamics Inc., Merit Medical Systems Inc., NIPRO Medical Corporation, IRadimed Corporation, Zyno Medical, Tricumed Medizintechnik GmbH, Q Core Medical Ltd., Ivenix Inc., Tandem Diabetes Care Inc.
What Are the Main Market Drivers in the Implantable Infusion Pumps Industry?
The escalating occurrence of individuals suffering from chronic pain, cancer, and diabetes is predicted to boost the demand for implantable infusion pumps. These devices are routinely employed to administer medicinal drugs during the management of these ailments. The emergence of chronic illnesses and disorders is escalating worldwide, spurred by an aging demographic and changes in societal behavior, bringing about a slow incline in such diseases. In cases like chronic arachnoiditis, a condition marked by swelling of a membrane that encloses the spinal cord, the provision of lower drug doses via implantable infusion pumps tends to offer enhanced pain mitigation. For example, a January 2022 report by the American Cancer Society, a health organization based in the US, indicates that 609,360 cancer-related deaths and nearly 1.9 million fresh instances of cancer are projected for 2022 in the US. About 10,470 pediatric cancer cases and 5,480 cancer diagnoses among teenagers are also forecasted for the same year. Thus, the escalating occurrence of chronic diseases is projected to spur the implantable infusion pumps market’s expansion.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=3347&type=smp
How Is the Implantable Infusion Pumps Market Segments Structured?
The implantable infusion pumps market covered in this report is segmented –
1) By Type: Patient-Controlled Analgesia (PCA) Pumps, Enteral Pumps, Insulin Pumps, Elastomeric Pumps, Syringe Pumps, Other Types
2) By Applications: Oncology, Pediatrics Or Neonatology, Gastroenterology, Hematology, Diabetes, Other Applications
3) By End User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics
Subsegments:
1) By Patient-Controlled Analgesia (PCA) Pumps: Morphine PCA Pumps, Fentanyl PCA Pumps, Other Opioid PCA Pumps
2) By Enteral Pumps: Tube Feeding Pumps, Syringe-based Enteral Pumps, Continuous Or Intermittent Feeding Pumps
3) By Insulin Pumps: Insulin Delivery Pumps, Insulin Patch Pumps, Smart Insulin Pumps
4) By Elastomeric Pumps: Disposable Elastomeric Pumps, Reusable Elastomeric Pumps
5) By Syringe Pumps: Small Volume Syringe Pumps, Large Volume Syringe Pumps
6) By Other Types: Chemotherapy Infusion Pumps, Antibiotic Infusion Pumps, Pain Management Pumps
What Strategic Trends Are Transforming the Implantable Infusion Pumps Market?
Firms operating in the implantable infusion pump market are progressively prioritizing the creation of intelligent infusion pumps. The incorporation of wireless technology in healthcare monitoring devices is on the rise, thereby improving user-friendliness, connectivity, and data analytics capacities. The inclusion of this wireless technology facilitates data transfer from the gadget to a mobile phone or other wireless hardware using Bluetooth or cellular linkage, which aids in data computation and result display. This can then be employed for additional scrutiny and to assess the person’s health status. Software platforms designed for patient monitoring and minimizing human mistakes are also being innovatively developed.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/implantable-infusion-pumps-global-market-report
Which Global Regions Offer the Highest Growth in the Implantable Infusion Pumps Market?
North America was the largest region in the implantable infusion pumps market in 2023. Asia-Pacific was the second-largest region in the implantable infusion pumps market. The regions covered in the implantable infusion pumps market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3347
This Report Delivers Insight On:
1. How big is the implantable infusion pumps market, and how is it changing globally?
2. Who are the major companies in the implantable infusion pumps market, and how are they performing?
3. What are the key opportunities and risks in the implantable infusion pumps market right now?
4. Which products or customer segments are growing the most in the implantable infusion pumps market?
5. What factors are helping or slowing down the growth of the implantable infusion pumps market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
